Traitement médical, thérapie génique et cellulaire de l’AOMI

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 ; 106: 3143-421. 2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344:1383-9. Dormandy, 2000, Management of peripheral arterial disease (PAD). Trans-Atlantic Inter-Society Consensus, J Vasc Surg, 31, S1 2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Yusuf, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients : the Heart Outcomes Prevention Evaluation Study Investigators, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301 Poldermans, 1999, The effect of bisoprolol on peri-operative mortality and myocardial infarction in high risk patients undergoing vascular surgery, N Engl J Med, 341, 1789, 10.1056/NEJM199912093412402 Poldermans, 2001, Bisoprolol reduces cardiac death and myocardial infarction in high-risk patientsas long as 2 years after successful major vascular surgery, Eur Heart J, 22, 1353, 10.1053/euhj.2000.2555 Creager, 2004, Atherosclerotic vascular disease conference: Writing Group V: medical decision making and therapy, Circulation, 109, 2634, 10.1161/01.CIR.0000128522.98016.19 Dorros, 2001, Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia (5-year follow-up), Circulation, 104, 2057, 10.1161/hc4201.097943 1999, Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1. Ischemia Cronica degli Arti Inferiori, Ann Intern Med, 130, 412, 10.7326/0003-4819-130-5-199903020-00005 Baumgartner, 1998, Constitutive expression of ph VEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia, Circulation, 97, 1114, 10.1161/01.CIR.97.12.1114 Tateishi-Yuyama, 2002, Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial, Lancet, 360, 427, 10.1016/S0140-6736(02)09670-8